Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
The portfolio includes branded injectable cephalosporines for infectious diseases
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Subscribe To Our Newsletter & Stay Updated
